CS

Chittathparampil Sankaranarayanan Bindu

Active Director Director DIN 10624950
DIN 10624950 First appointment May 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Chittathparampil Sankaranarayanan Bindu

Data last updated:

Chittathparampil Sankaranarayanan Bindu is a Director at Green Cross Pharma Federation (since 2024).

DIN 10624950
Primary Designation Director
First Appointment 13 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Green Cross Pharma Federation U86909KL2024NPL087609
Director13 May 20242024Active

Board colleagues of Chittathparampil Sankaranarayanan Bindu

Directorship timeline

Open interactive timeline →
Green Cross Pharma Federation
Premium access

Shareholding and investment profile for Chittathparampil Sankaranarayanan Bindu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chittathparampil Sankaranarayanan Bindu

Chittathparampil Sankaranarayanan Bindu currently holds 1 directorship: Green Cross Pharma Federation (Director, since 13 May 2024).

Chittathparampil Sankaranarayanan Bindu was first appointed on 13 May 2024 as Director at Green Cross Pharma Federation.

The current boards of Chittathparampil Sankaranarayanan Bindu's companies include Affadh Azeez (Green Cross Pharma Federation), Azeez Mathilakath Aneefa (Green Cross Pharma Federation), Moonnakkaparambil Muhammed Sajid (Green Cross Pharma Federation).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available